PA8807801A1 - Inhibidores de cinesina como productos terapeuticos para el cancer - Google Patents
Inhibidores de cinesina como productos terapeuticos para el cancerInfo
- Publication number
- PA8807801A1 PA8807801A1 PA20088807801A PA8807801A PA8807801A1 PA 8807801 A1 PA8807801 A1 PA 8807801A1 PA 20088807801 A PA20088807801 A PA 20088807801A PA 8807801 A PA8807801 A PA 8807801A PA 8807801 A1 PA8807801 A1 PA 8807801A1
- Authority
- PA
- Panama
- Prior art keywords
- inhibitors
- cancer
- compounds
- cinesine
- ksp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCIÓN PROPORCIONA NOVEDOSOS COMPUESTOS DE IMIDAZOL QUE INHIBEN LA ACTIVIDAD DE LA PROTEÍNA DE HUSO DE CINESINA(KSP,TAMBIÉN DENOMINADA COMO Eg5).LOS INHIBIDORES DE KSP PUEDEN REDUCIR LA PROLIFERACIÓN CELULAR INDESEADA,Y PROPORCIONAN OTROS EFECTOS TERAPÉUTICOS.LA INVENCIÓN TAMBIÉN PROPORCIONA COMPOSICIONES FARMACÉUTICAS QUE CONTIENE ESTOS COMPUESTOS NOVEDOSOS,Y MÉTODOS PARA UTILIZAR LOS INHIBIDORES DE KSP NOVEDOSOS Y SUS COMPOSICIONES FARMACÉUTICAS PARA TRATAR DIFERENTES TIPOS DE CÁNCERES. LOS COMPUESTOS,COMPOSICIONES Y MÉTODOS DE LA INVENCIÓN SON EN ESPECIAL ÚTILES PARA EL TRATAMIENTO DE CIERTAS CLASES DE CÁNCERES QUE SON RESISTENTES A LOS TRATAMIENTOS CON FÁRMACOS CONVENCIONALES,DEBIDO A QUE SE MUESTRA QUE ESTOS CÁNCERES SIGUEN SIENDO SENSIBLES A LOS COMPUESTOS DE LA INVENCIÓN.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1396607P | 2007-12-14 | 2007-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8807801A1 true PA8807801A1 (es) | 2009-07-23 |
Family
ID=40328566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20088807801A PA8807801A1 (es) | 2007-12-14 | 2008-12-12 | Inhibidores de cinesina como productos terapeuticos para el cancer |
Country Status (30)
Country | Link |
---|---|
US (2) | US8252832B2 (es) |
EP (1) | EP2229170B1 (es) |
JP (1) | JP5501976B2 (es) |
KR (1) | KR20100098394A (es) |
CN (1) | CN101939005B (es) |
AR (1) | AR069676A1 (es) |
AU (1) | AU2008337570B2 (es) |
BR (1) | BRPI0821248A2 (es) |
CA (1) | CA2708822A1 (es) |
CL (1) | CL2008003707A1 (es) |
CO (1) | CO6290651A2 (es) |
CR (1) | CR11412A (es) |
DO (1) | DOP2010000175A (es) |
EA (1) | EA018014B1 (es) |
EC (1) | ECSP10010248A (es) |
ES (1) | ES2459442T3 (es) |
GE (1) | GEP20125647B (es) |
GT (1) | GT201000172A (es) |
IL (1) | IL205831A0 (es) |
MA (1) | MA31872B1 (es) |
MY (1) | MY150214A (es) |
NI (1) | NI201000091A (es) |
NZ (1) | NZ585142A (es) |
PA (1) | PA8807801A1 (es) |
PE (1) | PE20091451A1 (es) |
SM (1) | SMP201000095B (es) |
TN (1) | TN2010000204A1 (es) |
TW (1) | TW200930704A (es) |
UY (1) | UY31532A1 (es) |
WO (1) | WO2009077448A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8349899B1 (en) | 2008-12-03 | 2013-01-08 | Arrowhead Center, Inc. | Selective inhibitors of EG5 motors and methods of use |
US8765817B1 (en) | 2008-12-03 | 2014-07-01 | Arrowhead Center, Inc. | Selective inhibitors of EG5 motors and methods of use |
EP2558452A2 (en) * | 2010-04-15 | 2013-02-20 | Novartis AG | Oxazole and thiazole compounds as ksp inhibitors |
US9498540B2 (en) | 2013-03-15 | 2016-11-22 | Novartis Ag | Cell proliferation inhibitors and conjugates thereof |
CN105451773A (zh) * | 2013-03-15 | 2016-03-30 | 诺华股份有限公司 | 细胞增殖抑制剂及其缀合物 |
US10786578B2 (en) | 2014-08-05 | 2020-09-29 | Novartis Ag | CKIT antibody drug conjugates |
MX2017017172A (es) * | 2015-06-22 | 2018-02-23 | Bayer Pharma AG | Conjugados de ligador-principio activo (adcs) y conjugados de ligador-profarmaco (apdcs) con grupos enzimaticamente escindibles. |
CN105418527A (zh) * | 2015-12-28 | 2016-03-23 | 青岛友诚高新技术有限公司 | 一种具有抗乳腺导管癌活性的化合物及其制备方法、用途 |
CN105646361B (zh) * | 2016-02-17 | 2017-12-01 | 吉首大学 | 一种2,4,5‑三芳基咪唑型化合物及其制法和用途 |
KR102556826B1 (ko) | 2016-12-21 | 2023-07-18 | 바이엘 파마 악티엔게젤샤프트 | 효소적으로 절단가능한 기를 갖는 항체 약물 접합체 (adc) |
CN106668863B (zh) * | 2017-02-21 | 2019-04-23 | 南方医科大学 | 靶向ktn1治疗皮肤鳞状细胞癌的药物 |
GB201706162D0 (en) * | 2017-04-19 | 2017-05-31 | Nat Univ Singapore | Compounds |
CN111954532A (zh) * | 2018-04-13 | 2020-11-17 | 上海交通大学医学院附属瑞金医院 | 杂芳基酰胺类化合物的抗肿瘤多药耐药性、治疗癌症的用途和蛋白质-药物分子复合物 |
CN109646679A (zh) * | 2019-01-28 | 2019-04-19 | 中国科学院长春应用化学研究所 | 铁离子螯合剂及其可药用盐的用途 |
CN111529526B (zh) * | 2020-04-14 | 2021-04-23 | 广州领晟医疗科技有限公司 | 一种化合物在制备治疗急性胰腺炎的药物中的用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2571002A1 (en) * | 2004-06-18 | 2006-01-05 | Chiron Corporation | N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
US7271271B2 (en) | 2004-06-28 | 2007-09-18 | Amgen Sf, Llc | Imidazolo-related compounds, compositions and methods for their use |
MY147188A (en) | 2005-08-09 | 2012-11-14 | Novartis Ag | Substituted imidazole compounds as ksp inhibitors |
BRPI0806264A2 (pt) | 2007-01-05 | 2011-08-30 | Novartis Ag | derivados ciclizados como inibidores de eg-5 |
-
2008
- 2008-11-25 US US12/313,923 patent/US8252832B2/en not_active Expired - Fee Related
- 2008-12-12 KR KR1020107012912A patent/KR20100098394A/ko not_active Application Discontinuation
- 2008-12-12 EP EP08863009.0A patent/EP2229170B1/en active Active
- 2008-12-12 BR BRPI0821248-1A patent/BRPI0821248A2/pt not_active IP Right Cessation
- 2008-12-12 ES ES08863009.0T patent/ES2459442T3/es active Active
- 2008-12-12 EA EA201000900A patent/EA018014B1/ru not_active IP Right Cessation
- 2008-12-12 PA PA20088807801A patent/PA8807801A1/es unknown
- 2008-12-12 AU AU2008337570A patent/AU2008337570B2/en not_active Ceased
- 2008-12-12 CL CL2008003707A patent/CL2008003707A1/es unknown
- 2008-12-12 NZ NZ585142A patent/NZ585142A/en not_active IP Right Cessation
- 2008-12-12 AR ARP080105410A patent/AR069676A1/es not_active Application Discontinuation
- 2008-12-12 PE PE2008002064A patent/PE20091451A1/es not_active Application Discontinuation
- 2008-12-12 MY MYPI2010002030A patent/MY150214A/en unknown
- 2008-12-12 GE GEAP200811846A patent/GEP20125647B/en unknown
- 2008-12-12 WO PCT/EP2008/067412 patent/WO2009077448A1/en active Application Filing
- 2008-12-12 CN CN200880120667.8A patent/CN101939005B/zh not_active Expired - Fee Related
- 2008-12-12 JP JP2010537460A patent/JP5501976B2/ja not_active Expired - Fee Related
- 2008-12-12 TW TW097148535A patent/TW200930704A/zh unknown
- 2008-12-12 CA CA2708822A patent/CA2708822A1/en not_active Abandoned
- 2008-12-15 UY UY31532A patent/UY31532A1/es not_active Application Discontinuation
-
2010
- 2010-05-05 CR CR11412A patent/CR11412A/es not_active Application Discontinuation
- 2010-05-07 TN TN2010000204A patent/TN2010000204A1/fr unknown
- 2010-05-17 IL IL205831A patent/IL205831A0/en unknown
- 2010-05-31 MA MA32879A patent/MA31872B1/fr unknown
- 2010-06-02 NI NI201000091A patent/NI201000091A/es unknown
- 2010-06-10 CO CO10070369A patent/CO6290651A2/es not_active Application Discontinuation
- 2010-06-11 DO DO2010000175A patent/DOP2010000175A/es unknown
- 2010-06-14 EC EC2010010248A patent/ECSP10010248A/es unknown
- 2010-06-14 GT GT201000172A patent/GT201000172A/es unknown
- 2010-07-13 SM SM201000095T patent/SMP201000095B/it unknown
-
2012
- 2012-07-11 US US13/546,713 patent/US8664256B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8807801A1 (es) | Inhibidores de cinesina como productos terapeuticos para el cancer | |
CL2023002090A1 (es) | Inhibidores de kras tricíclicos fusionados | |
DOP2019000020A (es) | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 | |
ECSP099445A (es) | Quinazolinas para la inhibición de pdk1 | |
NI201600058A (es) | Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de fgfr4 | |
DOP2022000082A (es) | Heterociclos bicíclicos como inhibidores de fgfr | |
GT200800202A (es) | Quinazolinas para la inhibicion de pdk1 | |
CL2008001743A1 (es) | Uso de un compuesto derivado de quinazolina para tratar el cancer; uso del compuesto y de otro compuesto antineoplasico; compuestos derivados de quinazolina; y composicion farmaceutica que los comprende. | |
DOP2021000017A (es) | Compuestos de pirimidina y composiciones farmaceuticas para prevenir o tratar cánceres que incluyen los mismos | |
CO2021006672A2 (es) | Moduladores de nlrp3 | |
ECSP20061378A (es) | COMPUESTOS DIÓLICOS DE AMINOPIRAZINA COMO INHIBIDORES DE PI3K-gamma | |
CL2019000661A1 (es) | Inhibidores de dopamina–b–hidroxilasa penetrantes de la barrera hematoencefálica. | |
UY35136A (es) | Métodos para tratar el cáncer de ovario con antagonistas de dll4. | |
BR112017014793A2 (pt) | regime de dosagem para antagonistas de madcam | |
UY39477A (es) | Compuestos espiro heterocíclicos y métodos de uso | |
CO2022002573A2 (es) | Anticuerpos contra ilt2 y uso de los mismos | |
CL2021001656A1 (es) | Compuestos de imidazopiridina e imidazopiridina y sus usos. | |
ECSP22098041A (es) | Inhibidores alostéricos de egfr y métodos de uso de estos | |
CO2020013834A2 (es) | Ciertos compuestos de pladienolida y métodos de uso | |
BR112017022296A2 (pt) | métodos para tratar câncer | |
CL2023000121A1 (es) | Anticuerpos anti-il-36r para el tratamiento de dermatosis neutrófilas | |
CU20100121A7 (es) | Inhibidores de cinesina como productos terapéuticos para el cáncer | |
CO2019001967A2 (es) | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 | |
AR099931A1 (es) | Combinaciones de agentes terapéuticos contra cáncer | |
DOP2009000143A (es) | Quinazolinas para la inhibicion de pdk1 |